These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18414714)

  • 21. AIH: Which Alternative for Difficult-to-Treat Patients?
    Sebode M; Schramm C
    Dig Dis; 2015; 33 Suppl 2():83-7. PubMed ID: 26641096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Budesonide for juvenile autoimmune hepatitis? Not yet.
    Mieli-Vergani G; Vergani D
    J Pediatr; 2013 Nov; 163(5):1246-8. PubMed ID: 23932214
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 24. Budesonide induces complete remission in autoimmune hepatitis.
    Csepregi A; Röcken C; Treiber G; Malfertheiner P
    World J Gastroenterol; 2006 Mar; 12(9):1362-6. PubMed ID: 16552802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.
    Llovet LP; Horta D; Eliz MG; Berenguer M; Fábrega E; Sáez-Royuela F; García-Retortillo M; Torrijos YS; Romero-Gómez M; Fernández C; Domínguez EG; Parés A; Londoño MC
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2819-2821. PubMed ID: 30616023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy.
    Burak KW; Swain MG; Santodomingo-Garzon T; Lee SS; Urbanski SJ; Aspinall AI; Coffin CS; Myers RP
    Can J Gastroenterol; 2013; 27(5):273-80. PubMed ID: 23712302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.
    Pape S; Gevers TJG; Belias M; Mustafajev IF; Vrolijk JM; van Hoek B; Bouma G; van Nieuwkerk CMJ; Hartl J; Schramm C; Lohse AW; Taubert R; Jaeckel E; Manns MP; Papp M; Stickel F; Heneghan MA; Drenth JPH
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2068-2075.e2. PubMed ID: 30625402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
    Yu ZJ; Zhang LL; Huang TT; Zhu JS; He ZB
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):873-877. PubMed ID: 31150366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine induced biochemical remission in childhood autoimmune hepatitis.
    Franulović OZ; Rajacić N; Lesar T; Kuna AT; Morić BV
    Coll Antropol; 2012 Sep; 36(3):973-9. PubMed ID: 23213960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis.
    Zhang H; Yang J; Zhu R; Zheng Y; Zhou Y; Dai W; Wang F; Chen K; Li J; Wang C; Li S; Liu T; Abudumijiti H; Zhou Z; Wang J; Lu W; Wang J; Xia Y; Zhou Y; Lu J; Guo C
    Drug Des Devel Ther; 2015; 9():567-74. PubMed ID: 25632224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
    Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
    Díaz-González Á; Hernández-Guerra M; Pérez-Medrano I; Sapena V; Riveiro-Barciela M; Barreira-Díaz A; Gómez E; Morillas RM; Del Barrio M; Escudé L; Mateos B; Horta D; Gómez J; Conde I; Ferre-Aracil C; El Hajra I; Arencibía A; Zamora J; Fernández A; Salcedo M; Molina E; Soria A; Estévez P; López C; Álvarez-Navascúes C; García-Retortillo M; Crespo J; Londoño MC;
    Hepatology; 2023 Apr; 77(4):1095-1105. PubMed ID: 36626622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
    Zachou K; Gatselis N; Papadamou G; Rigopoulou EI; Dalekos GN
    J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience.
    Karakoyun M; Ecevit CO; Kilicoglu E; Aydogdu S; Yagci RV; Ozgenc F
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):927-30. PubMed ID: 27254777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment.
    De Lemos-Bonotto M; Valle-Tovo C; Costabeber AM; Mattos AA; Azeredo-da-Silva ALF
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):212-216. PubMed ID: 29227329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment.
    Lohse AW; Gil H
    J Hepatol; 2011 Apr; 54(4):837-9. PubMed ID: 21145822
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.
    Purnak T; Efe C; Kav T; Wahlin S; Ozaslan E
    Dig Dis Sci; 2017 Oct; 62(10):2900-2907. PubMed ID: 28871464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis.
    Gassert DJ; Garcia H; Tanaka K; Reinus JF
    Dig Dis Sci; 2007 Sep; 52(9):2433-7. PubMed ID: 17429719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
    Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.